Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · IEX Real-Time Price · USD
4.200
-0.080 (-1.87%)
Jul 22, 2024, 10:00 AM EDT - Market open
Alaunos Therapeutics Employees
Alaunos Therapeutics had 1 employees as of December 31, 2023. The number of employees decreased by 33 or -97.06% compared to the previous year.
Employees
1
Change (1Y)
-33
Growth (1Y)
-97.06%
Revenue / Employee
$5,000
Profits / Employee
-$26,774,000
Market Cap
6.76M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Telesis Bio | 147 |
Sunshine Biopharma | 44 |
Pulmatrix | 22 |
Notable Labs | 16 |
Tenax Therapeutics | 6 |
Virios Therapeutics | 4 |
Cadrenal Therapeutics | 4 |
Xenetic Biosciences | 4 |
TCRT News
- 8 months ago - Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Top 5 Health Care Stocks That Could Blast Off This Month - Allakos (NASDAQ:ALLK), BioLife Solns (NASDAQ:BLFS) - Benzinga
- 1 year ago - Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics Reports First Quarter 2023 Financial Results - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023 - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting - GlobeNewsWire